Gene editing advances offer permanent cures
Gene editing technology "CRISPR" has entered a stage of scientific and clinical maturity after a decade since its discovery. It has evolved into an integrated system of tools capable of rewriting the genetic code with high precision. These challenges and advancements are expected to continue over the next five years, with the launch of three new genetic medicines and the expansion of treatments to include complex diseases such as Alzheimer's and Parkinson's, utilizing advanced techniques like prime editing and secure delivery methods. The development of a global governance framework is also crucial to ensure the ethical and responsible use of these technologies, as genetic modifications raise ethical and legal questions about the boundaries of intervention in nature and the rights of future generations.
Notice: This Is an AI-Generated Summary
Comments (0)